This study examines the IL-11 mediated activation of downstream signaling and expression of effector molecules to resolve the controversies associated with the IL-11 mediated regulation of the invasiveness of two commonly used trophoblastic cell models viz. JEG-3 and HTR-8/SVneo cells. It has been reported that IL-11 increases the invasiveness of JEG-3 cells while, reduces the invasiveness of HTR-8/SVneo cells. Invasion assay performed simultaneously for both the cell lines confirmed the above findings. In addition, HTR-8/SVneo cells showed a higher basal invasiveness than JEG-3 cells. Western blot showed the IL-11 mediated activation of STAT3(tyr705) and STAT1(tyr701) in both the cell lines. However, IL-11 activated the ERK1/2 phosphorylation in JEG-3 cells but, inhibited it in HTR-8/SVneo cells. Within 10 min of IL-11 treatment, p-STAT3(tyr705) was localized inside the nucleus of both the cell lines but, there was enhanced co-localization of protein inhibitor of activated STAT1/3 (PIAS1/3) and p-STAT3(tyr705) in HTR-8/SVneo cells and not in JEG-3 cells. This could be reason for the poor responsiveness of STAT3 responsive genes like mucin 1 (MUC1) in HTR-8/SVneo cells and not in JEG-3 cells. Further, microarray analysis of the IL-11 treated cells revealed differential responsiveness of JEG-3 as compared to HTR-8/SVneo cells. Several family of genes like activator protein-1 (AP-1) transcription factors (Jun and Fos), mucin-type molecules, MMP23B etc showed enhanced expression in IL-11 treated JEG-3 cells while, there was no response or decrease in their expression in IL-11 treated HTR-8/SVneo cells. Expression of these molecules was confirmed by quantitative RT-PCR. In addition, HTR-8/SVneo cells also showed a significant decrease in the expression of MMP2, MMP3 and MMP9 upon IL-11 treatment. Hence, IL-11 mediated differential activation of signaling and expression of effector molecules is responsible for the differential invasive response of JEG-3 and HTR-8/SVneo cells.
References
[1]
Goldman-Wohl D, Yagel S (2002) Regulation of trophoblast invasion: from normal implantation to pre-eclampsia. Mol Cell Endocrinol 187: 233–238.
[2]
Wells M (2007) The pathology of gestational trophoblastic disease: recent advances. Pathology 39: 88–96.
[3]
Guzeloglu-Kayisli O, Kayisli UA, Taylor HS (2009) The role of growth factors and cytokines during implantation: endocrine and paracrine interactions. Semin Reprod Med 27: 62–79.
[4]
Paiva P, Menkhorst E, Salamonsen L, Dimitriadis E (2009) Leukemia inhibitory factor and interleukin-11: critical regulators in the establishment of pregnancy. Cytokine Growth Factor Rev 20: 319–328.
[5]
Bilinski P, Roopenian D, Gossler A (1998) Maternal IL-11Ralpha function is required for normal decidua and fetoplacental development in mice. Genes Dev 12: 2234–2243.
[6]
Robb L, Li R, Hartley L, Nandurkar HH, Koentgen F, et al. (1998) Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat Med 4: 303–308.
[7]
Chen HF, Lin CY, Chao KH, Wu MY, Yang YS, et al. (2002) Defective production of interleukin-11 by decidua and chorionic villi in human anembryonic pregnancy. J Clin Endocrinol Metab 87: 2320–2328.
[8]
Koumantaki Y, Matalliotakis I, Sifakis S, Kyriakou D, Neonaki M, et al. (2001) Detection of interleukin-6, interleukin-8, and interleukin-11 in plasma from women with spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 98: 66–71.
[9]
Suman P, Poehlmann TG, Prakash GJ, Markert UR, Gupta SK (2009) Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression. J Reprod Immunol 82: 1–11.
[10]
Paiva P, Salamonsen LA, Manuelpillai U, Dimitriadis E (2009) Interleukin 11 inhibits human trophoblast invasion indicating a likely role in the decidual restraint of trophoblast invasion during placentation. Biol Reprod 80: 302–310.
[11]
Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, et al. (1993) Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 206: 204–211.
[12]
Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 4: 3.
[13]
Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44–57.
[14]
Bilban M, Tauber S, Haslinger P, Pollheimer J, Saleh L, et al. (2010) Trophoblast invasion: assessment of cellular models using gene expression signatures. Placenta 31: 989–996.
[15]
Xu G, Chakraborty C, Lala PK (2001) Expression of TGF-beta signaling genes in the normal, premalignant, and malignant human trophoblast: loss of smad3 in choriocarcinoma cells. Biochem Biophys Res Commun 287: 47–55.
[16]
Xu G, Chakraborty C, Lala PK (2002) Restoration of TGF-beta regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells. Biochem Biophys Res Commun 294: 1079–1086.
[17]
Xu G, Chakraborty C, Lala PK (2003) Reconstitution of Smad3 restores TGF-beta response of tissue inhibitor of metalloprotease-1 upregulation in human choriocarcinoma cells. Biochem Biophys Res Commun 300: 383–390.
[18]
Xu G, Guimond MJ, Chakraborty C, Lala PK (2002) Control of proliferation, migration, and invasiveness of human extravillous trophoblast by decorin, a decidual product. Biol Reprod 67: 681–689.
[19]
Iacob D, Cai J, Tsonis M, Babwah A, Chakraborty C, et al. (2008) Decorin-mediated inhibition of proliferation and migration of the human trophoblast via different tyrosine kinase receptors. Endocrinology 149: 6187–6197.
[20]
Khan GA, Girish GV, Lala N, Di Guglielmo GM, Lala PK (2011) Decorin is a novel VEGFR-2-binding antagonist for the human extravillous trophoblast. Mol Endocrinol 25: 1431–1443.
[21]
Yagel S, Parhar RS, Jeffrey JJ, Lala PK (1988) Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells. J Cell Physiol 136: 455–462.
[22]
Pollheimer J, Knofler M (2005) Signalling pathways regulating the invasive differentiation of human trophoblasts: a review. Placenta 26: Suppl AS21–S30.
[23]
Mossman BT, Gruenert DC (2002) SV40, growth factors, and mesothelioma: another piece of the puzzle. Am J Respir Cell Mol Biol 26: 167–170.
[24]
Schuringa JJ, Timmer H, Luttickhuizen D, Vellenga E, Kruijer W (2001) c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 response element (IRE). Cytokine 14: 78–87.
[25]
Gao J, McConnell MJ, Yu B, Li J, Balko JM, et al. (2009) MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion. Int J Oncol 35: 337–345.
[26]
Thirkill TL, Cao T, Stout M, Blankenship TN, Barakat A, et al. (2007) MUC1 is involved in trophoblast transendothelial migration. Biochim Biophys Acta 1773: 1007–1014.
[27]
Wicki A, Christofori G (2007) The potential role of podoplanin in tumour invasion. Br J Cancer 96: 1–5.
[28]
Khachaturyan L, Poehlmann TG, Weber M, Forti ALL, Morales DM, et al. (2010) Protein inhibitors of activated STATs (PIAS) control major trophoblastic functions. J Reproduktionsmed Endokrinol 7: 120–121.
[29]
Librach CL, Feigenbaum SL, Bass KE, Cui TY, Verastas N, et al. (1994) Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem 269: 17125–17131.
[30]
Qiu Q, Yang M, Tsang BK, Gruslin A (2004) EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways. Reproduction 128: 355–363.
[31]
Fitzgerald JS, Tsareva SA, Poehlmann TG, Berod L, Meissner A, et al. (2005) Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells. Int J Biochem Cell Biol 37: 2284–2296.
[32]
Jovanovic M, Stefanoska I, Radojcic L, Vicovac L (2010) Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1. Reproduction 139: 789–798.
[33]
Velasco G, Pendás AM, Fueyo A, Kn？uper V, Murphy G, et al. (1999) Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem 274: 4570–4576.
[34]
Pei D, Kang T, Qi H (2000) Cysteine array matrix metalloproteinase (CA-MMP)/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation. J Biol Chem 275: 33988–33997.
[35]
Damsky CH, Librach C, Lim KH, Fitzgerald ML, McMaster MT, et al. (1994) Integrin switching regulates normal trophoblast invasion. Development 120: 3657–3666.
[36]
Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR (2008) Cadherin switching. J Cell Sci 121: 727–735.
